As global interest in Dutch retreats grows, psilocybin truffle guides and groups have come together to establish self-regulation and best practices for those who offer guided tripping.
Researcher and professor Dr. Charles Grob discusses The Lundquist Institute’s announcement of a new multi-site clinical trial examining psilocybin for palliative care, the first study of its kind since the 1960’s, in this Q & A with Lucid News.
A newly published review calls for more research into psilocybin’s potential to treat obsessive-compulsive disorder (OCD) based on promising findings and anecdotal reports.
Researchers at the University of North Carolina use new techniques to create medicines that duplicate the effectiveness of ketamine and psilocybin as treatments for depression without the psychoactive effects.